1 / 6

How to cope with Brazil's ANVISA Regulatory Challenges

The Brazilian Health Surveillance Agency, commonly known as ANVISA, abbreviated from Portuguese u201cAgencia Nacional de Vigilancia Sanitaria,u201d is the food and drug regulatory agency in Brazil. In the federal public regulatory structure, the agency is connected to the Ministry of Health.

vistaarai
Télécharger la présentation

How to cope with Brazil's ANVISA Regulatory Challenges

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. How to cope with ANVISA's Regulatory Challenges

  2. Brazil Regulatory AuthorityANVISA – Regulatory Challenges The Brazilian Health Surveillance Agency, commonly known as ANVISA, abbreviated from Portuguese “Agencia Nacional de Vigilancia Sanitaria,” is the food and drug regulatory agency in Brazil. In the federal public regulatory structure, the agency is connected to the Ministry of Health. ANVISA has a particular process in which they undertake regulatory submissions. Over the years there have been several changes to these guidelines and the greatest challenge faced by bio and pharmaceutical companies in this regards is their lack of proper knowledge.

  3. Brazil Regulatory AuthorityANVISA – Regulatory Challenges Second visible challenge with ANVISA is that the regulations are present only in two languages, one is Portuguese and the other is English. The English version is not for all the content and hence it might be difficult for those without knowledge of Portuguese to comprehend. ANVISA’s registration process is often compared to that of the registration process of the US FDA because of certain uncanny resemblance.

  4. Brazil Regulatory Authority ANVISA – Regulatory Challenges In case of drugs the updated norms indicate that every drug and Active Pharmaceutical Ingredients (APIs) whether manufactured in Brazil or has been imported needs to be registered under ANVISA. This is an established regulatory system that has been running over the years but still there is extreme complexity surrounding the registration process under the same. ANVISA is a new ICH member and thus is going through a revision process of all guidelines. Most updated guidelines under this regulatory authority is presented in a detailed manner and with a proper structure which prevents manufacturers from taking the risk.

  5. Challenges Faced by ANVISA Challenges Highlighted by ANVISA Solution for Regulatory Challges Read now at Brazil Regulatory Authority ANVISA – Regulatory Challenges

  6. Thank You

More Related